REVENUE OF 130.2MILLION,UP5130.2 MILLION, UP 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF 130.2MILLION,UP515.3 MILLION; EX-ITEMS, 14.5MILLION,UPOVER2314.5 MILLION, UP OVER 23% SEQUENTIALLY AND DOWN 11% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF 11%, EXPANDED 160 BASIS POINTS SEQUENTIALLY, WITH INCREMENTAL MARGINS, EX-ITEMS, OF 41% GAAP EPS OF 14.5MILLION,UPOVER230.22; EX-ITEMS, 0.19,UP330.19, UP 33% SEQUENTIALLY, AND DOWN 14% YEAR-OVER-YEAR COMPANY REPURCHASED 237,632 SHARES OF COMMON STOCK, A VALUE OF 0.19,UP332.7 MILLION FREE CASH FLOW OF $10.4 MILLION, UP OVER 160% ...
e Laboratories (US:CLB) Prnewswire·2025-07-24 05:15